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A central problem of the current studies on protooncogenes (cellular onco-
genes, c-onc) is their role in the control of growth and differentiation of normal
cells. The cfos protooncogene has been widely investigated and it has been
demonstrated that cfos specific transcripts are induced in proliferating cells (1,
2) and during differentiation (3-6) . In particular, when HL60 (promyelocytic)
and U937 (promonocytic cell line) are induced to differentiate to cells with the
characteristics of monocytes/macrophages by treatment withPMA or IFN-1' (4-
6), cfos mRNA is detectable within 10 min . Similarly, when the murine myelo-
monocytic leukemia WEHI-3B was induced to differentiate to monocytes by
granulocyte colony-stimulating factor (GCSF) and Actinomycin D, expression of
cfos was seen (4) . Along the same line, when human myeloid leukemias at
different stages of differentiation were examined, cfos transcripts were only
detectable in the more mature monocytic forms (7) . Moreover, freshly isolated
murine peritoneal macrophages express appreciable levels of cfos-specific
mRNA, which can be augmented by endotoxin (8) and colony-stimulating factor
1 (CSF-1) (4) . Thus, although expression of cfos may be neither sufficient nor
obligatory for the differentiation ofmononuclear phagocytes (6), and it has been
suggested (6) that cfos expression plays a role only in growth arrest ofimmature
myeloid elements, its consistent association with mononuclear phagocytes sug-
gests that this protooncogene may be important in this hematopoietic pathway .
Since HL60 cells induced to differentiate to granulocytes do not express appre-
ciable levels ofcfostranscripts (5), expression of this protooncogene in leukocytes
in the absence of proliferation appears restricted to monocytes/macrophages .
We have examined the presence of cfos-specific transcripts in freshly isolated
human leukocyte populations . Unexpectedly, polymorphonuclear leukocytes
(PMN) constitutively expressed high levels of cfosmRNA . Monocytes expressed
appreciable cfos transcripts, though at much lower levels than PMN, and lymph-
oid cells showed no detectable expression . Exposure of PMN to agents that
stimulate their function resulted in augmented levels of cfos transcripts . Thus,
expression of this protooncogene is not peculiar, among circulating leukocytes,
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to mononucler phagocytes, and constitutive and inducible cfos expression may
play a role in the regulation of terminally differentiated circulating myeloid cells.
Materials and Methods
Cells.
￿
Leukocyte populations were purified as described in detail (9). Briefly, lympho-
cytes deprived of monocyte contamination (<I%) were obtained by adherence on plastic
followed by passage through a nylon wool column. Monocytes (>95% pure, usually 97-
98%) were purified using a one-step discontinuous Percoll (46%) (Pharmacia Fine Chem-
icals, Uppsala, Sweden) gradient (9). PMN were isolated by dextran sedimentation (9). In
selected experiments, PMN populations were further deprived of monocytes by treatment
with a monocyte-specific mAb (UCHM1; reference 9, a kind gift of Dr. P. C. L. Beverly,
University College, London, United Kingdom) and rabbit complement (Cederlane Lab-
oratories Ltd., Hornby, Ontario, Canada). The final mononuclear contamination was
<1% . As previously reported (10), the ratio of platelets to white cells was <0.5:1, as
judged by phase-contrast light microcopy, and we were not able to detect any platelet
contamination of PMN populations. The addition of platelet-enriched plasma (10%) to
leukocytes or differentiated HL-60 cells did not affect the levels of cfos expression.
All culture media and reagents were checked for endotoxin contamination by Limulus
Amebocyte Assay (sensitivity 0.1-0.2 ng/ml; Microbiological Associates, Walkersville,
MD) and found to be negative.
Stimuli.
￿
Human recombinant tumor necrosis factor (hrTNF; batch LYM12-10148B;
sp act, 1 .5 X 107 U/mg protein) was a kind gift of Dr. L. S. Lin (Cetus Corp., Emeryville,
CA). Human recombinant granulocyte and granulocyte/macrophage colony-stimulating
factor (hrGCSF and hrGMCSF, sp act 8 X 107 and 4 X 107 U/ml respectively) were
obtained from Dr. L. Souza (AMGene, Thousands Oaks, CA) and Dr. S. Gillis (Immunex
Corp., Seattle, Washington).
PMN in RPMI 1640 medium 10% FCS (Gibco, Glasgow, United Kingdom) (5 X 106
cells/ml) were incubated with the various agents (1-20 h) at various concentrations.
Cycloheximide (CH) and PMA were from Sigma Chemical Co., St. Louis, MO; inactivated
streptococci (OK-432) were from Chugai Pharmaceutical Ltd., Tokyo, Japan. HL60 and
U937 were induced to differentiate by culturing 3 X 106-106 cells/ml in complete medium
for 1 h to 3 d in the presence of PMA (20 ng/ml) or (HL60 cells) DMSO (1 .5% vol/vol).
Analysis ofcfos mRNA level.
￿
Total cellular RNA was isolated by guanidine isothiocya-
nate method (11). To avoid nucleic acid degradation by cytoplasmatic enzymes, in
particular during isolation of RNA from PMN, the entire procedure was carried out in
ice-cold conditions. 15 wg of RNA, unless otherwise stated, were analyzed by electropho-
resis through 1 % agarose formaldehyde gels, followed by Northern blot transfer to Gene
Screen Plus membranes (New England Nuclear, Boston, MA). The plasmids pc-fos-3 (5)
and a actin were labeled to high specific activity with a-["P]dCTP (3,000 Ci/mmol;
Radiochemical Center, Buckingamshire, United Kingdom) by nick translation (11). Mem-
branes were pretreated and hybridized in 50% formamide (Merck & Co., Rahway, NJ)
with 10% dextran sulfate (Sigma Chemical Co.) and washed two times with 2X SSC (IX
SSC: 0.15 M sodium chloride, 0.015 M sodium citrate) and 1 % SDS (Merck & Co.) at
60'C for 30 min and finally two times with 0.1 X SSC at room temperature for 30 min.
The membranes were exposed for 12-48 h at -80 ° C using intensifying screens. cfos
probe was removed from membranes according to manufacturer's instruction and then
hybridized to a actin probe under the same experimental conditions.
Results
We examined the presence of cfos transcripts in leukocyte populations ob-
tained from normal healthy donors. As shown in Fig. 1, RNA from lymphoid
cells carefully deprived of phagocytes (<I% contaminating monocytes) showed
no detectable hybridization signal (lane 1). In contrast, freshly isolated mono-
cytes, in the absence of deliberate stimulation, expressed appreciable levels of c-1226
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FIGURE 1 .
￿
Expression of cfos protooncogene in mye-
lomonocytic cell lines and human peripheral blood leu-
kocytes . RNA samples (15 ag) were as follows : (lane 1)
peripheral blood lymphocytes; (lane 2) uninduced U937
cells ; (lane 3) TPA-induced (20 ng/ml, 1-h treatment)
U937 cells ; (lane 4) DMSO-induced (1.5% vol/vol, 3-d
treatment) HL60 cells ; (lane 5) peripheral blood mono-
cytes ; (lane 6) peripheral blood PMN .
fos-related transcripts (lane 5) . These results extend to circulating human mon-
ocytes previous observations on cfosexpression in mononuclear phagocytesfrom
mice (4, 8) or in vitro differentiated cell lines (4, 5) . Moreover, as expected (5),
HL60 (data not shown) and U937 (Fig . 1, lane 3) induced to differentiate to
monocytes/macrophages by PMA treatment expressed cfos transcripts . In con-
trast to our expectations based on previous reports (5) that were confirmed by
us (Fig . 1, lane 4), on HL60 induced to differentiate to granulocytes, PMN
showed high levels of cfos transcripts, with a hybridization band of 2.2 kb (Fig .
1, lane 6) . In addition to the major 2.2-kb band, a weak hybridization band of
2 .0 kb was visible, presumably caused by rfos transcripts (5). The faint band at
^-3 .5 kb signal has been suggested to represent an unprocessed transcript (5) (see
also Fig. 2) . The results presented in Fig . 1 were obtained withPMN preparations
that contained <2% contamination with mononuclear cells. The high levels of c-
fos-specific transcripts were also found (data not shown) when PMN were treated
with an antimonocyte mAb (UCHM1) and complement (<I% contaminating
mononuclear cells) . This finding, together with the fact that PMN had consid-
erably higher levels of cfos transcripts than purified monocytes (Fig. 1), excludes
that cfos expression inPMN is related to contaminating monocytes :
cfos transcripts have been shown to be superinduced by exposure to cyclohex-
imide (5, 6) . Superinduction by CH was also found in PMN (Fig. 2, A 4, B lanes
3-4) .
It has been shown that exposure of murine macrophages to LPS, which
activates these cells but does not induce proliferation, and other agents, such as
PMA and CSF-1 (reference 8 and Introna, M ., personal communication), results
in induction of transcripts of cfos protooncogene. This prompted us to examine
whether stimuli that modulate a number of functions of PMN altered cfos
transcription . In addition to PMA and bacterial products (inactivated strepto-
cocci, OK-432), classical inducers of various PMN functions, we chose for these
experiments GCSF and GMCSF and TNF, since these cytokines have recently
been shown to regulate various granulocyte functions (12-14) . These stimuli
enhanced the levels of cfos transcripts (Fig . 2) . Densitometric analysis revealed
a two- to sixfold increase (10 experiments) of the 2.2-kb hybridization band . No
proliferation of the terminally differentiated peripheral blood PMN occurredCOLOTTA ET AL.
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FIGURE 2 .
￿
Expression of cfos protooncogene in stimulated human peripheral blood PMN.
A, B, and C represent three different experiments . RNAsamples (15 jig except for A, lane 5,
in which 6 jug ofRNA were applied to the gel) were as follows: (A) (lane 1) : uninduced U937
cells ; (lane 2) PMA-induced U937 cells; (lane 3) peripheral bloodPMN; (lane 4) cycloheximide-
treated (10 wg/ml, 1 h) PMN; (lane 5) TNF-treated (400 U/ml, 1 h) PMN; (lane 6) G-CSF-
treated (100 U/ml, 1 h) PMN; (lane 7) GM-CSF-treated (100 U/ml, 1 h) PMN. (B) (lane 1)
Peripheral bloodPMN; (lane 2) cycloheximide-stimulated (10 kg/ml, 1 h)PMN; (lane 3)PMA-
stimulated (20 ng/ml, 1 h) PMN; (lane 4) PMN stimulated with PMAand cycloheximide; (lane
5) TNF-stimulated (400 U/ml, 1 h) PMN. (C) (lane 1) Peripheral blood PMN; (lane 2)
inactivated streptococci (OK-432ystimulated (0 .1 mg/ml, 1 h) PMN.
after exposure to these agents, as assessed by [-H]TdR incorporation (results not
shown) .
Comparable levels of a actin transcripts were detected in various leukocyte
populations and afterPMN stimulation (not shown), thus excluding artifacts due
to different transfer efficiency of RNAs or changes in total cellularmRNA .
The expression of cfos gene was detectable also after 20 h of culture ofPMN;
the inducibility of cfos was still detectable after 20 h of culture usingPMA and
TNF (data not shown) .
Discussion
The results presented here demonstrate that freshly isolated PMN have high
levels of cfos transcripts . High cfos expression in PMN is detectable in the
absence of deliberate stimulation, after a separation carried out under Limulus-
negative conditions . It is also noteworthy that monocytes had no procoagulant
activity, a sensitive indicator of endotoxin contamination (10) . Moreover, similar
results were obtained when Polymixin B (I wg/ml) was added throughout the
separation procedure . It can therefore be operationally defined as constitutive .
It is also noteworthy in this respect that cfos transcripts in PMN were still
detectable after 20 h of culture, whereas expression of this protooncogene
associated with proliferation (1-2) and expression in macrophages augmented
by LPS (8) are short-lived.
Expression of cfos is associated with differentiation along the mono-
cyte/macrophage lineage (4-8), and HL60-derived granulocytes do not express
cfos (5), an observation confirmed by us (Fig . 1, lane 4). The apparent discrep-
ancy between results with HL60-derived granulocytes and freshly isolatedPMN1228
￿
COLOTTA ET AL.
￿
BRIEF DEFINITIVE REPORT
is intriguing. The DMSO-driven differentiation of HL60 cells may not be
representative of the in vivo conditions . CSF-1 has been shown to induce cfos
expression in murine macrophages (4), and it can be speculated that exposure to
CSF during hematopoiesis is responsible for the presence of cfos transcripts in
PMN. In possible agreement with this hypothesis, in vitro exposure to GCSF and
GMCSF enhanced cfos expression in PMN.
PMN are terminally differentiated cells, incapable of proliferation, with mini-
mal capacity to synthetize proteins and RNA and a definite lifespan in vitro and
in vivo (15). However, various cytokines, such as TNF and CSF, potentiate
various PMN functions (12-14). These cytokines, as well as classical stimuli of
phagocytes (PMA and bacterial products), increase the levels of cfos transcripts
in PMN and this protooncogene may be involved in regulating the functional
status of mature myelocytes.
In conclusion, unlike HL60-derived granulocytes, freshly isolated PMN show
high levels of cfos transcripts, and in the myelomonocytic differentiation path-
way, expression of this protooncogene is not peculiar to commitment to the
mononuclear phagocyte system. Terminally differentiated circulating mature
PMN may represent a privileged system in which the possible link between
protooncogene expression and stimulation of cell function, in the absence of
proliferation, can be investigated.
Summary
We have investigated by Northern blot analysis the expression of cfos pro-
tooncogene in human peripheral blood polymorphonuclear leukocytes (PMN).
Freshly isolated PMN, unlike highly purified circulating lymphoid cells, showed
high levels of cfos transcripts. Appreciable cfos mRNA was detected in mono-
cytes, but in lesser amounts compared with PMN. Upon exposure to a series of
agents that functionally stimulate granulocytes (PMA, inactivated streptococci,
TNF, granulocyte and granulocyte/macrophage colony-stimulating factor), a
considerable increase in cfos transcripts was detected. Expression ofcfos in PMN
was superinduced by exposure to cycloheximide. These data indicate that the
myelomonocytic differentiation pathway cfos expression is not peculiar to mon-
ocytes/macrophages and that PMN may represent a suitable system with which
to investigate the link between protooncogene expression and functional activa-
tion.
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